Skip to main content
Top
Published in: Clinical Rheumatology 8/2017

01-08-2017 | Original Article

Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients

Authors: Suad Hannawi, Issa AlSalmi, Ingrid Moller, Esperanza Naredo

Published in: Clinical Rheumatology | Issue 8/2017

Login to get access

Abstract

Rheumatoid arthritis (RA) is associated with increased cardiovascular disease (CVD) mortality and morbidity, due to the combined effects of traditional and non-traditional cardiovascular risk factors (CV). A serum uric acid (SUA) level has been suggested as one of the non-traditional cardiovascular risk factors. Cardiovascular risk can be assessed by looking at the subclinical atherosclerosis such as ultrasound (US)-measured carotid intima-media thickness (cIMT). This paper aimed to determine the role of SUA as a cardiovascular risk factor, along with the traditional cardiovascular risk factors and inflammation, among RA population. RA patients with no clinically evident CV or renal disease were studied. cIMT US, SUA, traditional cardiovascular, and inflammatory markers were obtained and correlated with cIMT. Among 53 RA patients (5 males, 48 females, mean age 48 ± 14 years), univariate linear-regression showed a positive linear relationship between cIMT and age (p < 0.001), age at RA symptoms onset and diagnosis (p = 0.010 and 0.003, respectively), number of cigarettes/day (p < 0.001), systolic and diastolic blood pressure (p = 0.005 and 0.030, respectively), and SUA (p = 0.007). Rheumatoid factor positivity and level were associated with thicker cIMT (p = 0.042 and 0.039, respectively). SUA maintained a significant correlation with cIMT in the multivariate analysis together with age, low-density lipoprotein, and triglyceride level. The model explained 55% (R2 55) of the causes of thick cIMT among RA population. SUA seems to be a cardiovascular risk factor in RA, as manifested by increase in the cIMT.
Literature
1.
2.
go back to reference Gibofsky A (2012) Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18:S295–S302PubMed Gibofsky A (2012) Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18:S295–S302PubMed
3.
go back to reference Tang MW, Koopman FA, Visscher JP, de Hair MJ, Gerlag DM, Tak PP (2017) Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis-contribution of free fatty acids to an increased cardiovascular risk during very early disease. Clin Rheumatol 36:269–278CrossRefPubMed Tang MW, Koopman FA, Visscher JP, de Hair MJ, Gerlag DM, Tak PP (2017) Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis-contribution of free fatty acids to an increased cardiovascular risk during very early disease. Clin Rheumatol 36:269–278CrossRefPubMed
4.
go back to reference Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697CrossRefPubMed Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697CrossRefPubMed
5.
go back to reference Meune C, Touzé E, Trinquart L, Allanore Y (2010) High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis 103:253–261CrossRefPubMed Meune C, Touzé E, Trinquart L, Allanore Y (2010) High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis 103:253–261CrossRefPubMed
6.
go back to reference del Rincon ID, Williams K, Stem MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737–2745CrossRefPubMed del Rincon ID, Williams K, Stem MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737–2745CrossRefPubMed
7.
go back to reference Chavan VU, Ramavataram D, Patel PA, Rupani MP (2015) Evaluation of serum magnesium, lipid profile and various biochemical parameters as risk factors of cardiovascular diseases in patients with rheumatoid arthritis. J Clin Diagn Res 9:BC01–BC05PubMedPubMedCentral Chavan VU, Ramavataram D, Patel PA, Rupani MP (2015) Evaluation of serum magnesium, lipid profile and various biochemical parameters as risk factors of cardiovascular diseases in patients with rheumatoid arthritis. J Clin Diagn Res 9:BC01–BC05PubMedPubMedCentral
8.
go back to reference Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum uric acid and the risk for hypertension and type d diabetes in Japanese men: the Osaka Health Survey. J Hypertens 19:1209–1215CrossRefPubMed Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum uric acid and the risk for hypertension and type d diabetes in Japanese men: the Osaka Health Survey. J Hypertens 19:1209–1215CrossRefPubMed
9.
go back to reference Milionis HJ, Kakafika A, Tsouli SG et al (2004) Effects of statin treatment on uric acid homeostasis inpatients with primary hyperlipidemia. Am Heart J 148:635–640CrossRefPubMed Milionis HJ, Kakafika A, Tsouli SG et al (2004) Effects of statin treatment on uric acid homeostasis inpatients with primary hyperlipidemia. Am Heart J 148:635–640CrossRefPubMed
10.
go back to reference Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST (1995) Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome: the Normative Aging Study. Am J Epidemiol 142:288–294CrossRefPubMed Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST (1995) Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome: the Normative Aging Study. Am J Epidemiol 142:288–294CrossRefPubMed
11.
go back to reference Cappuccio FP, Strazzullo P, Parinaro E, Trevisan M (1993) Uric acid metabolism and tubular sodium handling: results from a population-based study. JAMA 270:354–359CrossRefPubMed Cappuccio FP, Strazzullo P, Parinaro E, Trevisan M (1993) Uric acid metabolism and tubular sodium handling: results from a population-based study. JAMA 270:354–359CrossRefPubMed
12.
go back to reference Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S (2004) Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 27:227–233CrossRefPubMed Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S (2004) Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 27:227–233CrossRefPubMed
13.
go back to reference Johnson RJ, Kang DH, Feig D et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190CrossRefPubMed Johnson RJ, Kang DH, Feig D et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190CrossRefPubMed
14.
go back to reference Kang DH, Nakagawa T, Feng L et al (2002) A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13:2888–2897CrossRefPubMed Kang DH, Nakagawa T, Feng L et al (2002) A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13:2888–2897CrossRefPubMed
15.
go back to reference O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340:14–22CrossRefPubMed O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340:14–22CrossRefPubMed
16.
go back to reference Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96:1432–1437CrossRefPubMed Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96:1432–1437CrossRefPubMed
17.
go back to reference de Groot E, Hovinagh K, Wiegman A et al (2004) Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109:33–38CrossRef de Groot E, Hovinagh K, Wiegman A et al (2004) Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109:33–38CrossRef
18.
go back to reference Chambless LE, Folsom AR, Clegg LX et al (2000) Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 151:478–487CrossRefPubMed Chambless LE, Folsom AR, Clegg LX et al (2000) Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 151:478–487CrossRefPubMed
19.
go back to reference Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7:403–422CrossRefPubMed Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7:403–422CrossRefPubMed
20.
go back to reference Fan AZ, Paul-Labrador M, Merz CN, Iribarren C, Dwyer JH (2006) Smoking status and common carotid artery intima-medial thickness among middle-aged men and women based on ultrasound measurement: a cohort study. BMC cardiovasc disor 6:42CrossRef Fan AZ, Paul-Labrador M, Merz CN, Iribarren C, Dwyer JH (2006) Smoking status and common carotid artery intima-medial thickness among middle-aged men and women based on ultrasound measurement: a cohort study. BMC cardiovasc disor 6:42CrossRef
21.
go back to reference Johnson HM, Douglas PS, Srinivasan SR et al (2007) Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. Stroke 38:900–905CrossRefPubMed Johnson HM, Douglas PS, Srinivasan SR et al (2007) Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. Stroke 38:900–905CrossRefPubMed
22.
go back to reference Panoulas VF, Millionis HJ, Douglas KM et al (2007) Association of serum uric acid with cardiovascular disease in rheumatoid arthritis. Rheum (Oxford) 46:1466–1470CrossRef Panoulas VF, Millionis HJ, Douglas KM et al (2007) Association of serum uric acid with cardiovascular disease in rheumatoid arthritis. Rheum (Oxford) 46:1466–1470CrossRef
23.
go back to reference Panoulas VF, Douglas KM, Milionis HJ et al (2008) Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis. J Hum Hypertens 22:177–182CrossRefPubMed Panoulas VF, Douglas KM, Milionis HJ et al (2008) Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis. J Hum Hypertens 22:177–182CrossRefPubMed
24.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
25.
go back to reference Patetsios P, Song M, Shutze WP et al (2001) Identification of uric acid and xanthine oxidase in atherosclerotic plague. Am J Cardiol 88:188–191CrossRefPubMed Patetsios P, Song M, Shutze WP et al (2001) Identification of uric acid and xanthine oxidase in atherosclerotic plague. Am J Cardiol 88:188–191CrossRefPubMed
26.
go back to reference Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA (1973) Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 132:401–410CrossRefPubMed Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA (1973) Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 132:401–410CrossRefPubMed
27.
go back to reference Klein BE, Klein R, Lee KE (2002) Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 25:1790–1794CrossRefPubMed Klein BE, Klein R, Lee KE (2002) Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 25:1790–1794CrossRefPubMed
28.
go back to reference Hannawi S, Marwick TH, Thomas R (2009) Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 11:R51CrossRefPubMedPubMedCentral Hannawi S, Marwick TH, Thomas R (2009) Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 11:R51CrossRefPubMedPubMedCentral
29.
go back to reference Khosla UM, Zharikov S, Finch JL et al (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739–1742CrossRefPubMed Khosla UM, Zharikov S, Finch JL et al (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739–1742CrossRefPubMed
30.
go back to reference Kanbay M, Seqal M, Afsar B, Kang DH, Rodriquez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759–766CrossRefPubMed Kanbay M, Seqal M, Afsar B, Kang DH, Rodriquez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759–766CrossRefPubMed
31.
go back to reference Rao GN, Corson MA, Berk BC (1991) Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266:8604–8608PubMed Rao GN, Corson MA, Berk BC (1991) Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266:8604–8608PubMed
32.
go back to reference Kanellis J, Watanabe S, Li JH, Kang DH et al (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41:1287–1293CrossRefPubMed Kanellis J, Watanabe S, Li JH, Kang DH et al (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41:1287–1293CrossRefPubMed
33.
go back to reference Kanellis J, Kang DH (2005) Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 25:39–42CrossRefPubMed Kanellis J, Kang DH (2005) Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 25:39–42CrossRefPubMed
34.
go back to reference Kang DH, Park SK, Lee IK, Johnson RJ (2005) Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553–3562CrossRefPubMed Kang DH, Park SK, Lee IK, Johnson RJ (2005) Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553–3562CrossRefPubMed
35.
go back to reference Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1998) Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425–428CrossRefPubMed Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1998) Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425–428CrossRefPubMed
36.
go back to reference Jacobsson LT, Turesson C, Hanson RL et al (2001) Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum 44:1170–1176CrossRefPubMed Jacobsson LT, Turesson C, Hanson RL et al (2001) Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum 44:1170–1176CrossRefPubMed
37.
go back to reference Hannawi S, Haluska B, Marwick TH, Thomas R (2007) Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 9:R116CrossRefPubMedPubMedCentral Hannawi S, Haluska B, Marwick TH, Thomas R (2007) Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 9:R116CrossRefPubMedPubMedCentral
38.
go back to reference Soubrier M, Barber Chmoux N, Tatar Z, Couderc M, Dubost JJ, Mathiew S (2014) Cardiovascular risk in rheumatoid arthritis. Joint Bone Spine 81:298–302CrossRefPubMed Soubrier M, Barber Chmoux N, Tatar Z, Couderc M, Dubost JJ, Mathiew S (2014) Cardiovascular risk in rheumatoid arthritis. Joint Bone Spine 81:298–302CrossRefPubMed
39.
go back to reference Chatterjee Adhikari M, Guin A, Chakraborty S, Sinhamahapatra P, Ghosh A (2012) Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 41:669–675CrossRefPubMed Chatterjee Adhikari M, Guin A, Chakraborty S, Sinhamahapatra P, Ghosh A (2012) Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 41:669–675CrossRefPubMed
40.
go back to reference Braunwald E (1997) Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369CrossRefPubMed Braunwald E (1997) Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369CrossRefPubMed
41.
go back to reference Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809CrossRefPubMed Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809CrossRefPubMed
42.
go back to reference Hayden MR, Tyagi SC (2004) Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond) 1:10CrossRef Hayden MR, Tyagi SC (2004) Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond) 1:10CrossRef
Metadata
Title
Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients
Authors
Suad Hannawi
Issa AlSalmi
Ingrid Moller
Esperanza Naredo
Publication date
01-08-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 8/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3737-z

Other articles of this Issue 8/2017

Clinical Rheumatology 8/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.